+

WO2007066130A3 - Composition veterinaire - Google Patents

Composition veterinaire Download PDF

Info

Publication number
WO2007066130A3
WO2007066130A3 PCT/GB2006/004597 GB2006004597W WO2007066130A3 WO 2007066130 A3 WO2007066130 A3 WO 2007066130A3 GB 2006004597 W GB2006004597 W GB 2006004597W WO 2007066130 A3 WO2007066130 A3 WO 2007066130A3
Authority
WO
WIPO (PCT)
Prior art keywords
endoparasites
veterinary composition
composition against
against endoparasites
benzimidiazole
Prior art date
Application number
PCT/GB2006/004597
Other languages
English (en)
Other versions
WO2007066130A2 (fr
Inventor
Alistair Couper
Mona Ferry
Lillian Cromie
Willy Blakely
Original Assignee
Norbrook Lab Ltd
Alistair Couper
Mona Ferry
Lillian Cromie
Willy Blakely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd, Alistair Couper, Mona Ferry, Lillian Cromie, Willy Blakely filed Critical Norbrook Lab Ltd
Publication of WO2007066130A2 publication Critical patent/WO2007066130A2/fr
Publication of WO2007066130A3 publication Critical patent/WO2007066130A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne l'utilisation d'un inhibiteur de la reproduction comprenant un salicylanilide pour la fabrication d'un médicament vétérinaire destiné à l'inhibition de la capacité reproductrice des endoparasites en développement et de la forme mature résultante infectant un hôte animal.
PCT/GB2006/004597 2005-12-09 2006-12-08 Composition veterinaire WO2007066130A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0525093.1 2005-12-09
GBGB0525093.1A GB0525093D0 (en) 2005-12-09 2005-12-09 Veterinary composition

Publications (2)

Publication Number Publication Date
WO2007066130A2 WO2007066130A2 (fr) 2007-06-14
WO2007066130A3 true WO2007066130A3 (fr) 2007-08-16

Family

ID=35735821

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/004597 WO2007066130A2 (fr) 2005-12-09 2006-12-08 Composition veterinaire

Country Status (4)

Country Link
AR (1) AR058298A1 (fr)
GB (2) GB0525093D0 (fr)
PE (1) PE20070809A1 (fr)
WO (1) WO2007066130A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2991173B1 (fr) 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
EA022327B1 (ru) * 2013-01-04 2015-12-30 Общество С Ограниченной Ответственностью "Рубикон" Инъекционное ветеринарное средство в форме раствора для борьбы с полиинвазиями животного и способ его получения
SG11201701928RA (en) 2014-09-12 2017-04-27 Antibiotx Aps Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
EP3403652A1 (fr) 2017-05-18 2018-11-21 Veterinärmedizinische Universität Wien Prévention et traitement de troubles associés au facteur de croissance 23 des fibroblastes (fgf23) incluant la maladie rénale chronique (ckd)
IT201800004309A1 (it) * 2018-04-09 2019-10-09 Trattamenti topici per la miasi oculare
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028887A1 (fr) * 1993-06-15 1994-12-22 The Australian National University Compositions anthelmintiques synergiques
WO2001060380A1 (fr) * 2000-02-16 2001-08-23 Phoenix Scientific, Inc. Formulation antiparasitaire et procede de fabrication de cette formulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028887A1 (fr) * 1993-06-15 1994-12-22 The Australian National University Compositions anthelmintiques synergiques
WO2001060380A1 (fr) * 2000-02-16 2001-08-23 Phoenix Scientific, Inc. Formulation antiparasitaire et procede de fabrication de cette formulation

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CAMPBELL A J ET AL: "A comparison of the activity of uncouplers of oxidative phosphorylation against the common liver fluke Fasciola hepatica.", MOLECULAR AND BIOCHEMICAL PARASITOLOGY DEC 1981, vol. 4, no. 3-4, December 1981 (1981-12-01), pages 139 - 147, XP008075946, ISSN: 0166-6851 *
CRUTHERS L R ET AL: "Efficacy of a tribromosalan and parbendazole composition against adult Fasciola hepatica in sheep.", RESEARCH IN VETERINARY SCIENCE JAN 1981, vol. 30, no. 1, January 1981 (1981-01-01), pages 122 - 123, XP008075915, ISSN: 0034-5288 *
FAIRWEATHER I ET AL: "Fasciolicides: efficacy, actions, resistance and its management.", VETERINARY JOURNAL (LONDON, ENGLAND : 1997) SEP 1999, vol. 158, no. 2, September 1999 (1999-09-01), pages 81 - 112, XP002423819, ISSN: 1090-0233 *
HANNA ET AL: "The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle", VETERINARY PARASITOLOGY, ELSEVIER SCIENCE, AMSTERDAM, NL, vol. 142, no. 1-2, 30 November 2006 (2006-11-30), pages 78 - 90, XP005714804, ISSN: 0304-4017 *
MARTIN R J: "Modes of action of anthelmintic drugs.", VETERINARY JOURNAL (LONDON, ENGLAND : 1997) JUL 1997, vol. 154, no. 1, July 1997 (1997-07-01), pages 11 - 34, XP004762615, ISSN: 1090-0233 *
MOLL L ET AL: "Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.", VETERINARY PARASITOLOGY 24 JUL 2000, vol. 91, no. 1-2, 24 July 2000 (2000-07-24), pages 153 - 158, XP008075942, ISSN: 0304-4017 *
STEVENSON C R ET AL: "THE EFFICACY OF FORMULATIONS OF TRICLABENDAZOLE AND IVERMECTIN IN COMBINATION AGAINST LIVER FLUKE (FASCIOLA HEPATICA) AND GASTRO-INTESTINAL NEMATODES IN CATTLE AND SHEEP AND SUCKING LICE SPECIES IN CATTLE", AUSTRALIAN VETERINARY JOURNAL, AUSTRALIAN VETERINARY ASSOCIATION, BRUNSWICK, AU, vol. 80, no. 11, November 2002 (2002-11-01), pages 698 - 701, XP008075909, ISSN: 0005-0423 *
SWAN G E ET AL: "EFFICACY OF IVERMECTIN AGAINST INTERNAL PARASITES OF SHEEP", JOURNAL OF THE SOUTH AFRICAN VETERINARY MEDICAL ASSOCIATION, PRETORIA,, SA, vol. 55, no. 4, December 1984 (1984-12-01), pages 165 - 169, XP008075921, ISSN: 0038-2809 *

Also Published As

Publication number Publication date
GB0624565D0 (en) 2007-01-17
PE20070809A1 (es) 2007-08-27
GB0525093D0 (en) 2006-01-18
AR058298A1 (es) 2008-01-30
WO2007066130A2 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
WO2007066130A3 (fr) Composition veterinaire
BRPI0607762B8 (pt) análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
EA200900392A1 (ru) Комбинированное лечение сахарного диабета
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
WO2007034196A3 (fr) Agents d'imagerie
WO2007100776A3 (fr) Compositions antimicrobiennes et méthodes pour verrouiller des cathéters
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
AR057456A1 (es) Inhibidores de la proteasa ns3 del vhc
CL2007002971A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
AR059203A1 (es) Composiciones para uso vaginal
CL2007003557A1 (es) Compuestos derivados de heterociclos de nitrogeno, inhibidores de la actividad sobre b-raf; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
AR109263A2 (es) Composición que comprende moxidectina
CL2007002970A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CY1117174T1 (el) ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ
WO2010047592A3 (fr) Mélange conservateur et ses applications
CL2004000710A1 (es) Composicion antimicrobiana y antiparasitaria formada por un antibiotico derivado del cloranfenicol o tianfenicol, un endectocida y por lo menos un vehiculo aceptable, y su uso para tratar enfermedades respiratorias y parasitarias de los bovinos.
CR9364A (es) Agentes endoparasiticidas
ATE409719T1 (de) Verfahren zur herstellung fester treibmittelpräparationen
AR056749A1 (es) Formulaciones de dosificacion oral de ibuprofeno organolepticamente aceptables metodos para su preparacion y uso
SV2008003139A (es) Profarmacos de penem
BRPI0720114A8 (pt) Uso de um antagonista beta-adrenérgico e antagonista ou agonista parcial de 5-ht1a combinados, método para tratar caquexia, e, antagonista beta-adrenérgico e antagonista ou agonista parcial de 5-ht1a combinados
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico
DK1220676T3 (da) Forebyggelse af colorektal cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06820466

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载